Alefacept is a genetically engineered immunosuppressive drug. It was sold under the brand name Amevive in Canada, the United States, Israel, Switzerland and Australia. In 2011, the …

2005年6月13日 · Alefacept is a recombinant fusion protein that binds CD2 and is used treat moderate to severe plaque psoriasis.

2024年12月20日 · Alefacept injection is used to treat chronic plaque psoriasis, which is a skin disease with red and white scales that don't go away. This medicine is given to patients who …

2023年5月3日 · Amevive (alefacept) is a protein that works by affecting the body's immune system to decrease plaques/dead skin cells used for the treatment of moderate to severe …

2024年8月23日 · Amevive is used to treat plaque psoriasis (raised, silvery flaking of the skin) in adults. Amevive may also be used for purposes not listed in this medication guide. You should …

2021年9月15日 · Alefacept is a recombinant fusion protein of lymphocyte function associated antigen-3 (LFA-3) and immunoglobulin G dimer that acts to block the activation of T cells, and …

Indicated for moderate-to-severe chronic plaque psoriasis. 15 mg IM qWeek x 12 weeks. Regimen of 12 weekly injections recommended. Retreatment with additional 12 week course …

Alefacept is the first biological agent approved by the US Food and Drug Administration (FDA) for the treatment of moderate to severe chronic plaque psoriasis. It is a full human fusion protein …

Alefacept (Amevive) is a drug prescribed to treat adult patients with with moderate to severe chronic plaque psoriasis. Side effects, drug interactions, warnings and precautions, dosage, …

Alefacept is one of the first biologics in the treatment of psoriasis. It selectively reduces CD45RO(+) memory T cells and inhibits T-cell activation. Clinical data support its safety and …